Publications by authors named "Boris Labar"

Claim this Profile
H
Hematopoietic stem cell transplantation in Zagreb: the first 40 years.
Boris Labar

Croat Med J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.
Safaa M Ramadan, Stefan Suciu, Marian J P L Stevens-Kroef, Roelof Willemze, Sergio Amadori, Boris Labar

Cancers (Basel)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
Markus Pfirrmann, Richard E Clark, Witold Prejzner, Michael Lauseker, Michele Baccarani, Boris Labar

Leukemia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms.
Ivana Horvat, Ana Boban, Renata Zadro, Margareta Radic Antolic, Ranka Serventi-Seiwerth, Boris Labar

Clin Lymphoma Myeloma Leuk· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
Gordana Tomac, Ines Bojanić, Sanja Mazić, Ivana Vidović, Mirela Raos, Boris Labar

Blood Transfus· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.
Stein-Erik Gullaksen, Jørn Skavland, Sonia Gavasso, Vinko Tosevski, Krzysztof Warzocha, Boris Labar

Haematologica· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of HLA allele and haplotype polymorphisms on donor matching in hematopoietic stem cell transplantation - Croatian experience.
Zorana Grubic, Katarina Stingl Jankovic, Marija Maskalan, Ranka Serventi-Seiwerth, Mirta Mikulic, Boris Labar

Hum Immunol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.
Igor Aurer, Damir Nemet, Zdravko Mitrović, Dino Dujmović, Sandra Bašić-Kinda, Boris Labar

Ann Hematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia.
Sanja Prijić, Ivo Ugrina, Boris Labar, Damir Nemet, Josip Batinić

Leuk Lymphoma· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
Michael Lübbert, Stefan Suciu, Anne Hagemeijer, Björn Rüter, Uwe Platzbecker, Boris Labar

Ann Hematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG).
Heiko Becker, Stefan Suciu, Björn Hans Rüter, Uwe Platzbecker, Aristoteles Giagounidis, Boris Labar

Ann Hematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism in Croatia - Croatian Cooperative Group for Hematologic Diseases (CROHEM) study.
Dražen Pulanić, Velka Gverić-Krečak, Zlatka Nemet-Lojan, Hrvoje Holik, Božena Coha, Boris Labar

Croat Med J· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Extracorporeal photopheresis in treatment of chronic graft versus host disease].
Ines Bojanić, Ranka Serventi Seiwerth, Sanja Mazić, Klara Dubravcić, Drago Batinić, Boris Labar

Lijec Vjesn· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients.
Josip Batinić, Zinaida Perić, Dragana Šegulja, James Last, Sanja Prijić, Boris Labar

Croat Med J· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies.
Margriet Oosterveld, Stefan Suciu, Petra Muus, Ulrich Germing, Michel Delforge, Boris Labar

Ann Hematol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial.
Mariam G Aslanyan, Leonie I Kroeze, Saskia M C Langemeijer, Theresia N Koorenhof-Scheele, Marion Massop, Boris Labar

Ann Hematol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Roelof Willemze, Stefan Suciu, Giovanna Meloni, Boris Labar, Jean-Pierre Marie

J Clin Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.
Barbara Deschler, Gabriele Ihorst, Uwe Platzbecker, Ulrich Germing, Eva März, Boris Labar

Haematologica· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia.
Francis Giles, François-Xavier Mahon, Bjorn Gjertsen, Ronan Swords, Boris Labar

Eur J Clin Invest· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia.
Dino Dujmovic, Igor Aurer, Ivo Radman, Ranka Serventi-Seiwerth, Snjezana Dotlic, Boris Labar

Acta Haematol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diagnostic approach and therapy for cytomegalovirus (CMV) infection following allogeneic stem cell transplantation].
Natasa Beader, Smilja Kalenić, Boris Labar

Lijec Vjesn· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of tumor necrosis factor microsatellite polymorphisms on patient survival following hematopoietic stem cell transplantation.
Katarina Stingl, Renata Zunec, Ranka Serventi-Seiwerth, Boris Labar, Zorana Grubić

Croat Med J· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.
Grzegorz W Basak, Gabor Mikala, Zdenek Koristek, Ozren Jaksic, Sandra Basic-Kinda, Boris Labar

Leuk Lymphoma· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis.
Nadira Durakovic, Vedran Radojcic, Ana Boban, Mirando Mrsic, Dubravka Sertic, Boris Labar

Intern Med· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.
Grzegorz W Basak, Ozren Jaksic, Zdenek Koristek, Gabor Mikala, Jiri Mayer, Boris Labar

Am J Hematol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis